Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

FDA Reports Shortage of Commonly Used Antibiotics

Por: NBC 6 South Florida World November 03, 2022

thumbnail

BSIP/UIG Via Getty Images One of the most commonly used antibiotics in the country, amoxicillin, is in short supply, federal health officials say.  from the Food and Drug Administration about an oral solution of the drug comes diminished inventory of the medication, which is prescribed to treat bacterial infections, including pneumonia and bronchitis. The department  a shortage for an oral powder. Amoxicillin is available in chewable tablets... + full article



Similar News

How to get rid of UTI: FDA to consider new antibiotic for urinary tract infections

ABC7 USA Health November 05, 2022

thumbnail.GSK said it would prepare its findings for publication in a medical journal and submit its data to the FDA for approval next year. That's about a year ahead of the study's anticipated completion date on the website clinicaltrials.gov.Stopping studies in such... + más

The Curious Irony of Avoiding Icky Public Bathrooms | Slate

FDA warns one type of amoxicillin, a common antibiotic for children, is in short supply | ABC News


Caffeine searches spike after FDA announces nationwide Adderall shortage

Newsweek USA Health October 18, 2022

thumbnailOne week after the U.S. Food and Drug Administration (FDA) announced a shortage of the immediate release formulation of amphetamine mixed salts, commonly referred to by the Adderall brand name, searches for caffeine vs. Adderall spiked on Google.The FDA posted the Adderall... + más

Did COVID-19 pandemic contribute to Adderall shortage? | ABC News

Did COVID-19 pandemic contribute to Adderall shortage? | ABC7


ALS drug wins FDA approval despite questionable data

ABC News USA Health September 30, 2022

thumbnailWASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.Amylyx Pharmaceuticals said the Food and... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | WPLG Local 10


ALS drug wins FDA approval despite questionable data

WPLG Local 10 USA Politics September 30, 2022

thumbnailWASHINGTON – A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | ABC News


FDA concedes delays in response to baby formula shortage

WPLG Local 10 USA Health September 24, 2022

thumbnailWASHINGTON – The Food and Drug Administration acknowledged Tuesday that its response to the U.S. was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.A 10-page report from the agency offers its first formal... + más

FDA concedes delays in response to baby formula shortage | ABC News

‘If the FDA is expected to do more, it needs more’: FDA investigation into baby-formula crisis points to its own shortcomings. But shortages persist. | MarketWatch


FDA concedes delays in response to baby formula shortage

ABC News USA Health September 21, 2022

thumbnailWASHINGTON -- The Food and Drug Administration acknowledged Tuesday that its response to the U.S. infant formula shortage was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.A 10-page report from the agency... + más

FDA concedes delays in response to baby formula shortage | Associated Press

Internal FDA report on infant formula crisis details shortfalls in response | ABC News


FDA concedes delays in response to baby formula shortage

Associated Press USA Politics September 21, 2022

thumbnailWASHINGTON (AP) — The Food and Drug Administration acknowledged Tuesday that its response to the U.S. was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.A 10-page report from the agency offers its first... + más

FDA concedes delays in response to baby formula shortage | ABC News

Internal FDA report on infant formula crisis details shortfalls in response | ABC News



About iurex | Privacy Policy | Disclaimer |